Model
Edge
Halozyme Therapeutics, Inc.
0001662521
Filing Type
4
Filing Date
5/4/2026
Updated
5/5/26, 3:05 PM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership